174 related articles for article (PubMed ID: 38831430)
1. Chrysanthemum morifolium Ramat extract and probiotics combination ameliorates metabolic disorders through regulating gut microbiota and PPARα subcellular localization.
Gao X; Zhu Z; Bao Y; Li Y; Zhu W; He X; Ge X; Huang W; Wang H; Wei W; Du J; Chen L; Li H; Sheng L
Chin Med; 2024 Jun; 19(1):76. PubMed ID: 38831430
[TBL] [Abstract][Full Text] [Related]
2. Chrysanthemum morifolium attenuates metabolic and alcohol-associated liver disease via gut microbiota and PPARα/γ activation.
Liu D; Zhan J; Wang S; Chen L; Zhu Q; Nie R; Zhou X; Zheng W; Luo X; Wang B; Nie J; Ye X
Phytomedicine; 2024 Jul; 130():155774. PubMed ID: 38820659
[TBL] [Abstract][Full Text] [Related]
3. Traditional Chinese Medicine formula Dai-Zong-Fang alleviating hepatic steatosis in
Zhang LW; Zhu LL; Zhu XY; Fu SQ; Liu XM
Front Pharmacol; 2024; 15():1337057. PubMed ID: 38327989
[No Abstract] [Full Text] [Related]
4. Lactobacillus plantarum FRT10 alleviated high-fat diet-induced obesity in mice through regulating the PPARα signal pathway and gut microbiota.
Cai H; Wen Z; Li X; Meng K; Yang P
Appl Microbiol Biotechnol; 2020 Jul; 104(13):5959-5972. PubMed ID: 32409945
[TBL] [Abstract][Full Text] [Related]
5. Ban-xia-xie-xin-tang ameliorates hepatic steatosis by regulating Cidea and Cidec expression in HFD-fed mice.
Xia QS; Gao Y; Wen-Bin W; Wu F; Dong H; Xu LJ; Fang K; Hu ML; Yuan F; Lu FE; Gong J
Phytomedicine; 2022 Oct; 105():154351. PubMed ID: 35908522
[TBL] [Abstract][Full Text] [Related]
6. A botanical dietary supplement from white peony and licorice attenuates nonalcoholic fatty liver disease by modulating gut microbiota and reducing inflammation.
Chen L; Kan J; Zheng N; Li B; Hong Y; Yan J; Tao X; Wu G; Ma J; Zhu W; Sheng L; Chen L; Li B; Zhong J; Du J; Li H
Phytomedicine; 2021 Oct; 91():153693. PubMed ID: 34403877
[TBL] [Abstract][Full Text] [Related]
7. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
[TBL] [Abstract][Full Text] [Related]
8. Smilax China L. polysaccharide prevents HFD induced-NAFLD by regulating hepatic fat metabolism and gut microbiota.
Zhang W; Yu L; Yang Q; Zhang J; Wang W; Hu X; Li J; Zheng G
Phytomedicine; 2024 May; 127():155478. PubMed ID: 38452696
[TBL] [Abstract][Full Text] [Related]
9. Folic acid attenuates high-fat diet-induced steatohepatitis
Xin FZ; Zhao ZH; Zhang RN; Pan Q; Gong ZZ; Sun C; Fan JG
World J Gastroenterol; 2020 May; 26(18):2203-2220. PubMed ID: 32476787
[TBL] [Abstract][Full Text] [Related]
10. Tangshen formula targets the gut microbiota to treat non-alcoholic fatty liver disease in HFD mice: A 16S rRNA and non-targeted metabolomics analyses.
Wang S; Li X; Zhang B; Li Y; Chen K; Qi H; Gao M; Rong J; Liu L; Wan Y; Dong X; Yan M; Ma L; Li P; Zhao T
Biomed Pharmacother; 2024 Apr; 173():116405. PubMed ID: 38484559
[TBL] [Abstract][Full Text] [Related]
11. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis.
Yin X; Liu Z; Wang J
Phytomedicine; 2023 Oct; 119():155005. PubMed ID: 37562090
[TBL] [Abstract][Full Text] [Related]
12. Hepatobiliary and pancreatic: Multi-donor fecal microbiota transplantation attenuated high-fat diet-induced hepatic steatosis in mice by remodeling the gut microbiota.
Shou D; Luo Q; Tang W; Cao C; Huang H; Chen H; Zhou Y
J Gastroenterol Hepatol; 2023 Dec; 38(12):2195-2205. PubMed ID: 37787118
[TBL] [Abstract][Full Text] [Related]
13. Lanzhang Granules Ameliorate Nonalcoholic Fatty Liver Disease by Regulating the PPAR
Huang P; Yang L; Liu Y; Jiang Y; Li Y; Chen Z; Song H; Zheng P
Evid Based Complement Alternat Med; 2022; 2022():1124901. PubMed ID: 35035496
[TBL] [Abstract][Full Text] [Related]
14. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
[TBL] [Abstract][Full Text] [Related]
15. Aqueous extract of fermented Eucommia ulmoides leaves alleviates hyperlipidemia by maintaining gut homeostasis and modulating metabolism in high-fat diet fed rats.
Duan Y; Guo F; Li C; Xiang D; Gong M; Yi H; Chen L; Yan L; Zhang D; Dai L; Liu X; Wang Z
Phytomedicine; 2024 Jun; 128():155291. PubMed ID: 38518640
[TBL] [Abstract][Full Text] [Related]
16. The metabolic and vascular protective effects of olive (Olea europaea L.) leaf extract in diet-induced obesity in mice are related to the amelioration of gut microbiota dysbiosis and to its immunomodulatory properties.
Vezza T; Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Romero M; Sánchez M; Toral M; Martín-García B; Gómez-Caravaca AM; Arráez-Román D; Segura-Carretero A; Micol V; García F; Utrilla MP; Duarte J; Rodríguez-Cabezas ME; Gálvez J
Pharmacol Res; 2019 Dec; 150():104487. PubMed ID: 31610229
[TBL] [Abstract][Full Text] [Related]
17. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
Wang P; Wang J; Li D; Ke W; Chen F; Hu X
J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated hepatic lipid metabolism and gut microbiota associated with early-stage NAFLD in ASPP2-deficiency mice.
Xie F; Xu HF; Zhang J; Liu XN; Kou BX; Cai MY; Wu J; Dong JL; Meng QH; Wang Y; Chen D; Zhang Y
Front Immunol; 2022; 13():974872. PubMed ID: 36466835
[TBL] [Abstract][Full Text] [Related]
19. Ling-Gui-Zhu-Gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota.
Chen L-p; Zhang L-f; Liu S; Hua H; Zhang L; Liu B-c; Wang R-r
Microbiol Spectr; 2024 Jun; 12(6):e0197923. PubMed ID: 38647315
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
